Testing an educational tool for melanoma patients with autoimmune conditions

This trial is testing a new educational tool designed specifically for patients who have melanoma and a pre-existing autoimmune disease (like rheumatoid arthritis, inflammatory bowel disease, or lupus) and are considering immune checkpoint inhibitor therapy. The study wants to see if this educational tool is easy to use, helpful, and accessible. Researchers will gather feedback from patients and doctors to make sure the tool works well in real-world clinical settings.

Patients with melanoma who also have an autoimmune condition face a challenging decision: immune checkpoint inhibitors can be powerful cancer treatments, but they may trigger or worsen autoimmune symptoms. This trial exists to create and test an educational resource that helps patients and doctors have informed conversations about the benefits and risks of this treatment approach for their specific situation.